Occudo Quantitative Strategies’s Royalty Pharma RPRX Stock Holding History

Occudo Quantitative Strategies’s Portfolio RPRX Stock Details RPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$9.26M	Buy	165,177 +43,377	+36%	+$2.26M	0.49%	42
2026 Q1	$6.1M	Buy	+121,800	New	+$5.33M	0.33%	86
2025 Q2	–	Sell	-78,380	Closed	-$2.46M	–	859
2025 Q1	$2.46M	Buy	78,380 +55,868	+248%	+$1.77M	0.33%	77
2024 Q4	$574K	Buy	22,512 +11,052	+96%	+$293K	0.1%	283
2024 Q3	$324K	Buy	+11,460	New	+$317K	0.06%	426
2022 Q4	–	Sell	-22,149	Closed	-$890K	–	1313
2022 Q3	$890K	Buy	+22,149	New	+$946K	0.07%	451
2021 Q4	–	Sell	-27,284	Closed	-$986K	–	1228
2021 Q3	$986K	Sell	27,284 -44,641	-62%	-$1.73M	0.12%	287
2021 Q2	$2.95M	Buy	71,925 +35,752	+99%	+$1.52M	0.45%	31
2021 Q1	$1.58M	Buy	36,173 +27,890	+337%	+$1.32M	0.35%	55
2020 Q4	$415K	Buy	+8,283	New	+$351K	0.13%	302

Other funds holding RPRX

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Occudo Quantitative Strategies's RPRX Position: Q2 2026 in Review

Occudo Quantitative Strategies increased its Royalty Pharma (RPRX) stake by 36% in Q2 2026, buying an estimated $2.26M and bringing the position to 165,177 shares worth $9.26M. The position accounts for 0.49% of the portfolio, ranked #42.

Occudo Quantitative Strategies first reported a position in RPRX in Q4 2020 and has held it in 10 quarters since. 643 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

Occudo Quantitative Strategies held 165,177 shares of Royalty Pharma worth $9.26M as of Q2 2026.
Occudo Quantitative Strategies bought 43,377 Royalty Pharma shares in Q2 2026, an estimated $2.26M.
Royalty Pharma made up 0.49% of Occudo Quantitative Strategies's portfolio in Q2 2026, its #42 holding.
Occudo Quantitative Strategies first reported a position in Royalty Pharma in Q4 2020 and has held it in 10 quarters since.
643 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on Occudo Quantitative Strategies's 13F filing for Q2 2026, filed 13 Aug 2026.